Nanohybrid Hydrogels Spatiotemporally Restore Infectious Bone Defects via Mitochondrial Homeostasis-Driven Immunomodulation and Vascular-Bone Coupling Synergy
Source abstract
Abstract
Regeneration of infected bone defects (IBDs) requires biomaterials capable of dynamically coordinating antimicrobial, anti-inflammatory, and osteogenic functions. Overcoming the spatiotemporal mismatches in treating IBDs remains a critical challenge. Here, we designed a temporally controlled therapy based on gelatin methacrylate (GelMA)-based nanocomposite hydrogels (GCS) coembedded with sulfur quantum dots (SQDs) nanoenzymes and calcium-phosphorus oligomers (CPOs.) The GCS platform enables a three-phase therapy targeting the healing of IBDs: (1) effective inactivation of bacteria is achieved by SQDs weakly interacting with the hydrogel after early and rapid release; (2) the mitochondrial homeostatic balance is maintained through SQDs-mediated reactive oxygen species scavenging that restores ATP synthesis, which in turn inhibits inflammatory cascade-associated protein expression and drives macrophage M2 polarization; and (3) sustained CPO delivery initiates vascular coupling and osteogenic differentiation during tissue regeneration. In a rat model of IBDs, GCS reached a complete bone bridge at week 8 with a 46.6 ± 2.3% new bone volume. This work pioneers nanozyme-driven mitochondrial-immune axis regulation through programmable material dynamics, offering a paradigm for functional hydrogel design in infected tissue regeneration.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Orthopedic Infections and Treatments · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Research Center for Nano-Biomaterial, Analytical and Testing Center
Sichuan University
The Affiliated Stomatological Hospital
Southwest Medical University
Clinical Medical College & Affiliated Hospital
Chengdu University
Funding
National Key Research and Development Program of China · National Natural Science Foundation of China
References (54)
Show source-provided references
1. 10.1002/adfm.20180791510.1002/adfm.201807915 ↗
2. 10.1016/j.jma.2024.07.01210.1016/j.jma.2024.07.012 ↗
3. 10.1002/adfm.20221473410.1002/adfm.202214734 ↗
4. 10.1038/s41423-020-0480-110.1038/s41423-020-0480-1 ↗
5. 10.1038/ni.371010.1038/ni.3710 ↗
6. Khan S. · 2023 · 374 · 159
7. 10.1038/s44324-024-00008-310.1038/s44324-024-00008-3 ↗
8. 10.1002/adma.20210843010.1002/adma.202108430 ↗
9. 10.1002/smll.20220691910.1002/smll.202206919 ↗
10. 10.1016/j.cell.2016.08.06410.1016/j.cell.2016.08.064 ↗
11. 10.1021/acsnano.3c0816510.1021/acsnano.3c08165 ↗
12. 10.1002/smmd.2023003410.1002/smmd.20230034 ↗
13. 10.1016/j.bmt.2022.11.00710.1016/j.bmt.2022.11.007 ↗
14. 10.1016/j.susmat.2024.e0110510.1016/j.susmat.2024.e01105 ↗
15. 10.1007/s10311-022-01495-w10.1007/s10311-022-01495-w ↗
16. 10.1016/j.cis.2020.10227410.1016/j.cis.2020.102274 ↗
17. 10.1016/j.colsurfb.2024.11386310.1016/j.colsurfb.2024.113863 ↗
18. 10.1021/acsnano.4c1234310.1021/acsnano.4c12343 ↗
19. 10.1016/j.ccr.2021.21417010.1016/j.ccr.2021.214170 ↗
20. 10.1002/adma.20240161910.1002/adma.202401619 ↗
21. 10.1126/sciadv.adf864510.1126/sciadv.adf8645 ↗
22. 10.7150/thno.9733510.7150/thno.97335 ↗
23. 10.7150/thno.10277910.7150/thno.102779 ↗
24. 10.1002/smll.20230011110.1002/smll.202300111 ↗
25. 10.1002/advs.20230464110.1002/advs.202304641 ↗
26. 10.1039/C1CS15203C10.1039/C1CS15203C ↗
27. 10.3390/jfb1304018710.3390/jfb13040187 ↗
28. 10.1021/acsami.2c1621710.1021/acsami.2c16217 ↗
29. 10.1002/idm2.1218110.1002/idm2.12181 ↗
30. 10.1002/adfm.20231642810.1002/adfm.202316428 ↗
31. 10.1038/s41586-019-1645-x10.1038/s41586-019-1645-x ↗
32. 10.1021/acsami.8b2117910.1021/acsami.8b21179 ↗
33. 10.1002/adhm.20200070910.1002/adhm.202000709 ↗
34. 10.1038/s41598-021-02830-x10.1038/s41598-021-02830-x ↗
35. 10.1038/nmat440710.1038/nmat4407 ↗
36. 10.1002/adma.20150537510.1002/adma.201505375 ↗
37. 10.1021/acsnano.9b0078810.1021/acsnano.9b00788 ↗
38. 10.1016/j.cej.2024.15533710.1016/j.cej.2024.155337 ↗
39. 10.1002/advs.20230696410.1002/advs.202306964 ↗
40. 10.1038/s41590-019-0539-210.1038/s41590-019-0539-2 ↗
41. 10.1038/s41580-020-0210-710.1038/s41580-020-0210-7 ↗
42. 10.1038/s41564-019-0542-210.1038/s41564-019-0542-2 ↗
43. 10.1016/j.actbio.2021.04.05210.1016/j.actbio.2021.04.052 ↗
44. 10.1038/s41467-022-34481-510.1038/s41467-022-34481-5 ↗
45. 10.1126/sciadv.aba431110.1126/sciadv.aba4311 ↗
46. 10.1002/adma.20240878710.1002/adma.202408787 ↗
47. 10.1002/adfm.20240074510.1002/adfm.202400745 ↗
48. 10.1002/adfm.20220896810.1002/adfm.202208968 ↗
49. 10.1016/j.compositesb.2020.10793710.1016/j.compositesb.2020.107937 ↗
50. 10.1002/adfm.20240156610.1002/adfm.202401566 ↗
51. 10.1002/advs.20230003810.1002/advs.202300038 ↗
52. 10.1016/j.actbio.2024.01.04310.1016/j.actbio.2024.01.043 ↗
53. 10.1186/s12951-022-01254-710.1186/s12951-022-01254-7 ↗
54. 10.1007/s11033-018-4488-x10.1007/s11033-018-4488-x ↗